Advanced searches left 3/3

Uterine Cancer - Europe PMC

Summarized by Plex Scholar
Last Updated: 07 June 2022

* If you want to update the article please login/register

Early cervical cancer and recurrence after minimally invasive surgery without uterine manipulator

"Objective: worldwide cervical cancer is the fourth most common cancer, and it is also the fourth leading cause of death among women after breast cancer, colorectal cancer, and lung cancer. " Materials: and methods: A single-center retrospective analysis was conducted at the Department of Obstetrics and Gynecology of ARNAS Garibaldi Nesima in 2013 to 2017. According to the FIGO classification, one of the thirty-one patients registered, twelve women died of cervical cancer stage IA2, ten cases of cervical cancer stage IA2, ten cases of cervical cancer stage IB1, and seven cases of cervical cancer stage IB2. Conclusion: Following five years of follow-up, recurrence rates in patients treated with minimally invasive surgery have declined by around 10%, but the use of uterine manipulators is not correlated to a higher rate of recurrence rates.

Source link: https://europepmc.org/article/PPR/PPR502961


Detection of parametrial invasion in women with uterine cervical cancer using diffusion tensor imaging at 1.5T MRI.

"Purpose": "Purpose" was the intent of this research was to objectively assess the lumbosacral plexus's ability to detect parametrial invasion by uterine cervical cancer. Materials and methods Twenty-seven women with biopsy-proven cervical cancer were prospectively registered and underwent DTI at 1. 5 TMRI. The differences between FA values of invaded parametria and those of non-invaded parametria were investigated using a Student t-test. In the absence of parametrial invasion, FA was more concerned about parametrial invasion than in the absence of parametrial invasion. According to a ROC review, the best cut-off value of FA for the diagnosis of parametrial invasion was > 0. 3099, giving 62% sensitivity, 73% specificity, and 66% accuracy. Conclusion Using > 0. 3099 as cut off-value for FA of L5-S1 roots, DTI has a 73% success in the diagnosis of parametrial invasion by uterine cervical cancer diagnosis.

Source link: https://europepmc.org/article/MED/35641417


Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning.

"Objectives" include conditional survival and risk assessment data for uterine serous carcinoma overall, as well as stratified by stage as tools for annual survivorship screening and care planning. Patients in the National Cancer Data Base were eligible between 2004 and 2014 with stage I-IV USC. According to year, age, and ethnicity, a standardized mortality ratio estimated the percentage of observed to expected deaths in the United States adjusted for year, age, and ethnicity. According to statistics, stage I, 52% vs. 72%, 72% vs. 81%, and stage III, 68 percent vs. 66%, respectively, with 19% vs. 60% for stage II USC. According to the figures, "2. 1 vs. 1. 68 for stage III disease, 1. 30 vs. 1. 68 for Medicaid insurance, 1. 01 vs. 2. 48 for stage III disease, and 6. 65 vs. 2. 79 for stage IV disease, respectively, decreased. ".

Source link: https://europepmc.org/article/MED/35624045


A novel nomogram for predicting cancer-specific survival in women with uterine sarcoma: a large population-based study.

"Background Uterine sarcoma is a rare malignant uterine tumor with aggressive appearance and rapid progress. " The aim of this research was to develop a comprehensive nomogram to predict cancer-specific survival of patients in the United States based on the Surveillance, Epidemiology, and End Results database. Methods A retrospective population-based study was conducted using data from patients in the United States between 2010 and 2015 from the SEER website. The findings of our study included a total of 3861 patients in the United States. Pathology grade had the highest correlation with CSS in our nomogram, followed by age at diagnosis and surgery status, followed by surgical age. With a higher C-index in the training and validation cohorts, the new nomogram provided better predictive discrimination than the AJCC staging scheme, with improved predictive accuracy. Conclusion The first comprehensive nomogram for the United States was published in our database, and it may help patients in clinical practice get more accurate and personalized survival estimates for U. S. patients.

Source link: https://europepmc.org/article/MED/35568940

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions